Skip to main content
NCBI home page
Gut logoLink to Gut
. 1996 Nov;39(5):661–667. doi: 10.1136/gut.39.5.661

Physiological control of cholecystokinin release and pancreatic enzyme secretion by intraduodenal bile acids.

I Koop 1, M Schindler 1, A Bosshammer 1, J Scheibner 1, E Stange 1, H Koop 1
PMCID: PMC1383388  PMID: 9026479

Abstract

BACKGROUND: The physiological relevance of duodenal bile acids in the control of cholecystokinin release and pancreatic enzyme secretion is still unknown. AIMS: To provide a near physiological situation by perfusing a bile acid mixture mimicking the individual endogenous bile acid composition of the person under investigation. For maximal reduction of endogenous bile output the CCK-A receptor antagonist loxiglumide was infused intravenously. SUBJECTS AND METHODS: Seven healthy volunteers were studied on four different days by a duodenal marker perfusion technique. The individual bile acid composition in duodenal juice and test meal stimulated bile acid output was assessed on day 1. Bile acids were perfused at an amount of 30 or 100% as determined on day 1 in combination with the test meal in the presence or absence of loxiglumide. Pancreatic enzymes, bilirubin, and bile acid output were determined in duodenal juice. Plasma cholecystokinin (CCK) and plasma pancreatic polypeptide (PP) were measured radioimmunologically. RESULTS: Bile acid perfusion did not significantly alter stimulated pancreatic enzyme, bilirubin or bile acid output or plasma CCK. Loxiglumide did not alter basal CCK release but increased test meal stimulated CCK output fourfold (p < 0.05). The addition of bile acids to the test meal at a dose resembling 30% of bile acid output as determined on day 1 prevented this increase. Plasma PP concentration remained unchanged by bile acids and were mostly undetectable during loxiglumide infusion. CONCLUSIONS: The CCK producing cell is under constant suppression by intraduodenal bile acids which cannot be further enhanced by a physiological bile acid mixture. However, removal of duodenal bile acids by inhibition of gall bladder contraction unmasks this suppression leading to a dramatic increase in plasma CCK levels. As little as one third of postprandially released bile acids completely reverse this effect. Bile acids are the most important luminal regulator of CCK release in humans.

Full text

PDF
661

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adler G., Beglinger C., Braun U., Reinshagen M., Koop I., Schafmayer A. Cholecystokinin is a regulator of intestinal phase-stimulated PP release. Regul Pept. 1990 Sep 10;30(2):105–111. doi: 10.1016/0167-0115(90)90051-w. [DOI] [PubMed] [Google Scholar]
  2. Björnsson O. G., Maton P. N., Fletcher D. R., Chadwick V. S. Effects of duodenal perfusion with sodium taurocholate on biliary and pancreatic secretion in man. Eur J Clin Invest. 1982 Apr;12(2):97–105. doi: 10.1111/j.1365-2362.1982.tb00945.x. [DOI] [PubMed] [Google Scholar]
  3. Forell M. M., Otte M., Kohl H. J., Lehnert P., Stahlheber H. P. The influence of bile and pure bile salts on pancreatic secretion in man. Scand J Gastroenterol. 1971;6(3):261–265. doi: 10.3109/00365527109180705. [DOI] [PubMed] [Google Scholar]
  4. Gomez G., Upp J. R., Jr, Lluis F., Alexander R. W., Poston G. J., Greeley G. H., Jr, Thompson J. C. Regulation of the release of cholecystokinin by bile salts in dogs and humans. Gastroenterology. 1988 Apr;94(4):1036–1046. doi: 10.1016/0016-5085(88)90564-1. [DOI] [PubMed] [Google Scholar]
  5. HUMMEL B. C. A modified spectrophotometric determination of chymotrypsin, trypsin, and thrombin. Can J Biochem Physiol. 1959 Dec;37:1393–1399. [PubMed] [Google Scholar]
  6. Hildebrand P., Beglinger C., Gyr K., Jansen J. B., Rovati L. C., Zuercher M., Lamers C. B., Setnikar I., Stalder G. A. Effects of a cholecystokinin receptor antagonist on intestinal phase of pancreatic and biliary responses in man. J Clin Invest. 1990 Mar;85(3):640–646. doi: 10.1172/JCI114486. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Janowitz P., Swobodnik W., Wechsler J. G., Zöller A., Kuhn K., Ditschuneit H. Comparison of gall bladder bile and endoscopically obtained duodenal bile. Gut. 1990 Dec;31(12):1407–1410. doi: 10.1136/gut.31.12.1407. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Koide M., Okabayashi Y., Otsuki M. Role of endogenous bile on basal and postprandial CCK release in humans. Dig Dis Sci. 1993 Jul;38(7):1284–1290. doi: 10.1007/BF01296080. [DOI] [PubMed] [Google Scholar]
  9. Koop I., Dorn S., Koop H., Witzleb S., Beglinger C., Schafmayer A., Arnold R. Dissociation of cholecystokinin and pancreaticobiliary response to intraduodenal bile acids and cholestyramine in humans. Dig Dis Sci. 1991 Nov;36(11):1625–1632. doi: 10.1007/BF01296408. [DOI] [PubMed] [Google Scholar]
  10. Koop I., Fellgiebel A., Koop H., Schafmayer A., Arnold R. Effect of cholestyramine on plasma cholecystokinin and pancreatic polypeptide levels, and exocrine pancreatic secretion. Eur J Clin Invest. 1988 Oct;18(5):517–523. doi: 10.1111/j.1365-2362.1988.tb01050.x. [DOI] [PubMed] [Google Scholar]
  11. Koop I., Koop H., Gerhardt C., Schafmayer A., Arnold R. Do bile acids exert a negative feedback control of cholecystokinin release? Scand J Gastroenterol. 1989 Apr;24(3):315–320. doi: 10.3109/00365528909093053. [DOI] [PubMed] [Google Scholar]
  12. Malagelada J. R., DiMagno E. P., Summerskill W. H., Go V. L. Regulation of pancreatic and gallbladder functions by intraluminal fatty acids and bile acids in man. J Clin Invest. 1976 Aug;58(2):493–499. doi: 10.1172/JCI108493. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Malagelada J. R., Go V. L., DiMagno E. P., Summerskill W. H. Interactions between intraluminal bile acids and digestive products on pancreatic and gallbladder function. J Clin Invest. 1973 Sep;52(9):2160–2165. doi: 10.1172/JCI107400. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Riepl R. L., Lehnert P., Scharl A., Hempen I., Fiedler F., Teufel J., Burhol P. G. Effect of intraduodenal bile and Na- taurodeoxycholate on exocrine pancreatic secretion and on plasma levels of secretin, pancreatic polypeptide, and gastrin in man. Scand J Gastroenterol. 1990 Jan;25(1):45–53. doi: 10.3109/00365529008999208. [DOI] [PubMed] [Google Scholar]
  15. Schafmayer A., Werner M., Becker H. D. Radioimmunological determination of cholecystokinin in tissue extracts. Digestion. 1982;24(3):146–154. doi: 10.1159/000198790. [DOI] [PubMed] [Google Scholar]
  16. Schmidt W. E., Creutzfeldt W., Höcker M., Nustede R., Choudhury A. R., Schleser A., Rovati L. C., Fölsch U. R. Cholecystokinin receptor antagonist loxiglumide modulates plasma levels of gastro-entero-pancreatic hormones in man. Feedback control of cholecystokinin and gastrin secretion. Eur J Clin Invest. 1991 Oct;21(5):501–511. doi: 10.1111/j.1365-2362.1991.tb01402.x. [DOI] [PubMed] [Google Scholar]
  17. Schmidt W. E., Creutzfeldt W., Schleser A., Choudhury A. R., Nustede R., Höcker M., Nitsche R., Sostmann H., Rovati L. C., Fölsch U. R. Role of CCK in regulation of pancreaticobiliary functions and GI motility in humans: effects of loxiglumide. Am J Physiol. 1991 Feb;260(2 Pt 1):G197–G206. doi: 10.1152/ajpgi.1991.260.2.G197. [DOI] [PubMed] [Google Scholar]
  18. Setnikar I., Bani M., Cereda R., Chisté R., Makovec F., Pacini M. A., Revel L. Anticholecystokinin activities of loxiglumide. Arzneimittelforschung. 1987 Oct;37(10):1168–1171. [PubMed] [Google Scholar]
  19. Setnikar I., Bani M., Cereda R., Chisté R., Makovec F., Pacini M. A., Revel L., Rovati L. C., Rovati L. A. Pharmacological characterisation of a new potent and specific nonpolypeptidic cholecystokinin antagonist. Arzneimittelforschung. 1987 Jun;37(6):703–707. [PubMed] [Google Scholar]
  20. Stern D. H., Walsh J. H. Gastrin release in postoperative ulcer patients: evidence for release of duodenal gastrin. Gastroenterology. 1973 Mar;64(3):363–369. [PubMed] [Google Scholar]
  21. Wildgrube H. J., Stockhausen H., Petri J., Füssel U., Lauer H. Naturally occurring conjugated bile acids, measured by high-performance liquid chromatography, in human, dog, and rabbit bile. J Chromatogr. 1986 Feb 26;353:207–213. doi: 10.1016/s0021-9673(01)87090-4. [DOI] [PubMed] [Google Scholar]
  22. You C. H., Rominger J. M., Chey W. Y. Potentiation effect of cholecystokinin-octapeptide on pancreatic bicarbonate secretion stimulated by a physiologic dose of secretin in humans. Gastroenterology. 1983 Jul;85(1):40–45. [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES